³Ô¹Ïtv

Professor Amanj Kurdi

³Ô¹Ïtv Institute of Pharmacy and Biomedical Sciences

Contact

Personal statement

Professor Kurdi is a Professor of Pharmacoepidemiology and Pharmacy Practice. He specialises in Pharmacoepidemiology and Drug Utilisation Research, especially concerning cardiovascular diseases, diabetes, and antibiotics. This includes studying medication adherence and persistence through the analysis of secondary databases and patient-level data, utilising a range of statistical and analytical methods.

Additionally, Professor Kurdi is keen on exploring Health Service Research and the evaluation of health policies and clinical guidelines' effects. Open to both national and international collaborations with fellow researchers and academics, Dr. Kurdi actively participates in events and conferences like EuroDURG and ICPE, fostering a collaborative environment for advancing research in these areas.

Back to staff profile

Prize And Awards

Recipient
1/6/2026
Recipient
24/2/2025
Recipient
16/11/2024
Recipient
1/3/2024
Recipient
11/2/2024
Recipient
31/1/2024

Back to staff profile

Publications

Zheng Bang, , Amstutz Alain, Green Amelia, Herrett Emily, Tazare John, Wen Qing, Mahalingasivam Viyaasan, Smith Rebecca, MacKenna Brian, Mehrkar Amir, Bacon Sebastian, Goldacre Ben, , Sheikh Aziz, Tomlinson Laurie
Nature Communications (2026)
Hamida Jalal Abu, Alkhatib Nimer S, Hammour Khawla Abu, Halloush Shiraz, , Balkhi Bander, Alfayez Osamah M, Mousa Rimal
Frontiers in Public Health Vol 14 (2026)
The 42nd ICPE Annual Meeting (2026)
The 42nd ICPE Annual Meeting (2026)
Munzhedzi Mukhethwa, Meyer Johanna, Chigome Audrey, Miljković Nenad, Moore Catrin E, Kumar Gauri, , Campbell Stephen M, Godman Brian
Advances in Human Biology (2026)
BSAC Spring Conference 2026 (2026)

Back to staff profile

Professional Activities

Participant
26/2/2026
Participant
26/2/2026
Speaker
29/10/2025
Organiser
7/7/2025
Organiser
4/6/2025
Examiner
24/2/2025

Projects

Kurdi, Amanj (Principal Investigator)
01-Jan-2026 - 31-Jan-2027
Elrggal, Mahmoud (CoPI) Kurdi, Amanj (Principal Investigator)
A 48 months project funded by The Saudi Basic Science Initiative, Research Development and Innovation Authority (RDIA), ~£300K
01-Jan-2025 - 30-Jan-2029
Alotaibi, Eman (Principal Investigator) Kurdi, Amanj (Principal Investigator) Alotaibi, Badriah (Academic)
01-Jan-2024 - 30-Jan-2025
Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher) Kavanagh, Kimberley (Co-investigator)
The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the ³Ô¹Ïtv, Public Health Scotland and the NHS Health Boards.
01-Jan-2024 - 31-Jan-2027
Parvin, Mst Irin (Principal Investigator) Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Principal Investigator)
Medication use during pregnancy can have detrimental effects on the mother as well as the unborn child, which might be unknown. Studies on medicine use during pregnancy can provide valuable information about the medications that pregnant women most frequently use for the diseases they are prescribed and whether or or not using these medications could be harmful for the mother and/or the unborn child. Findings from this scoping review will provide an insight of the medicines used during pregnancy as well as a comprehensive summary of the current evidence on this topic.
10-Jan-2024 - 14-Jan-2024
Kurdi, Amanj (Principal Investigator) Mueller, Tanja (Co-investigator)
01-Jan-2023 - 30-Jan-2028

Back to staff profile

Contact

Professor Amanj Kurdi
³Ô¹Ïtv Institute of Pharmacy and Biomedical Sciences

Email: amanj.baker@strath.ac.uk
Tel: 548 2181